spacer
home > epc > Winter 2002
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2002
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of EPC
   
Text
PDF
bullet
introduction
In his Editor's Letter, Dr Graham Hughes reviews the articles in this Winter issue of EPC  
view
bullet
Marketplace & Business
Until recently the idea of outsourcing pharmacovigilance activities fell outside the comfort zone of all but a few pharmaceutical companies. Liz Nowell, Pharmacovigilance Manager, Alan Rawling, Managing Director of Assured Information Systems and Dr Michael Bowden, Managing Director of the European Division, Health Decisions, discuss this new approach, in Meeting new Pharmacovigilance Challenges - the Need for Outsourcing  
view
In The Ethics of Research Related to Health Care in Developing Countries - Implications of the Report for the Pharmaceutical Industry, Professor Sir Kenneth Calman, Vice-Chancellor and Warden at the University of Durham, highlights the need to continue supporting future research as outlined in a report by the Nuffield Council on Bioethics  
view
John A Morris, Head of European Pharmaceuticals at KPMG, comments on recent developments threatening to wrest control of pricing further from the hands of pharmaceutical companies, in Pharma Companies Are Losing Control of Pricing  
view
bullet
Clinical Trials
Chris Tait, Head of Chubb Insurance, comments that careful risk management can minimise the potential for litigation, in Clinical Trials: Loss Prevention is Better Than Cure  
view
Parallel initiatives introduced in the US in the late 1990s have led to unprecedented growth in the field of paediatric clinical trials. Simon Robinson, Programme Director, International Paediatrics at Intercern, analyses this trend, in Paediatric Clinical Trials - Implications for Contractors  
view
bullet
Legal & Regulatory
Co-promotions often amply reward the participants and allow for collaborations that might not otherwise be consummated. In Prescription Drug Co-Promotion: 21st Century Dealmaking, David Schulman, David Wallis and Helen Hunsperger at International Law Firm Dechert, explore drug co-promotion activity  
view
In Managing Tax Payment - How to Avoid Paying Tax at 60 Per Cent or More, Andrew Hickman, European Regional Co-ordinator, and Emma Cuthbertson, Senior Manager in KPMG's London-based Global Transfer Pricing Services group, warn of the risk of double taxation and advise on how that risk can be managed  
view
bullet
e-Data
Dr Graham Bunn, Global Vice-President of e-Clinical Business at Quintiles, investigates the complexity, regulation, process inertia and employee resistance to EDC scale-up, in The Great Escape - From EDC Pilot to Full Scale Implementation  
view
In In or Out? - IT Outsourcing Options for Pharmaceutical Companies, Nick Robinson, CEO of Phoenix IT Services, outlines the need to exploit all market opportunities and suggests that much can be gained from managed services, ASP and outsourcing relationships  
view
bullet
Science & Innovation
In The Outlook for Central Nervous System Drug Development, Dr Faiz Kermani, Budgets, Proposals and Marketing Executive, and Stuart McGuire, Business Development Executive at Chiltern International examine the progress in developing new treatments for these complex disorders  
view
Traditionally, sponsors have included feasibility checks in the process of choosing a study site. In Assessing Study Feasibility in the Netherlands - A Research Site's Point of View, Dr Henk Mulder, Director of Osteosupport BV, outlines a sponsor's key considerations for validation of a research site  
view
bullet
LABS & Logistics
John Butterworth, Director of Clinical Trials Network at TNT Express, discusses the concept of providing a complete palette of logistics services to support clinical trials, in Improving Clinical Trial Logistics - A Courier's Perspective  
view
In Pharma Companies Must Jump on the Brand Wagon, Stephanie Loeffler, Partner at Marks & Clerk, considers the need for brand equity to be established and protected from the outset if it is to be profitable  
view
Richard Perkes, Technical Director at Cool Logistics, provides an overview of the direction in which the distribution industry is developing and outlines the options available for companies requiring improved performance from their temperature controlled packaging, in The Growing Importance of Cold Chain Distribution in the Pharmaceutical and Biotechnology Industries  
view
bullet
Finnish Focus
Biotechnology, especially its pharmaceutical sector, is regarded as one of the most promising areas of industry. In Biotechnology - A Challenge for Young Companies and Old Regulators, Pekka Kurki, MD, PhD, Senior Medical Officer at the Department of Pharmacology, National Agency for Medicines, Finland, analyses the challenges posed for industry  
view
In EDC Use in Clinical Trials: Are we on the Verge of a Breakthrough?, Mike Miller-Smith, Marketing Manager at CRF Box, raises important issues vital to the successful widespread adoption of electronic data capture (EDC) based on experiences gained both from a pharmaceutical company and vendor perspective  
view
Rainer Hilli, Partner and Tom Groop, Associate of Roschier Holmberg Attorneys Ltd, examine the Finnish Government's suggested procedure for generic substitution, in Generic Substitution - The Proposed Procedure for the Prescription of Pharmaceuticals in Finland  
view
bullet
Global Central Laboratories
For many years now, there has been centralisation of laboratory analysis for particular aspects of clinical trials. In Rationalised Analytical Laboratory Services for Tomorrow's Clinical Trials, John L Allinson, Laboratory Director of BAS Analytics in the UK, examines the potential for the bioanalytical and central laboratory to form a much closer working relationship  
view
Pharmaceutical and biotechnology companies have one thing in common: they rely on high quality laboratory results in order to evaluate the efficacy of their drugs. Dr Hermann Schulz, President and Co-Founder of INTERLAB GmbH, discusses this need, in Centralised Laboratory Testing for Clinical Trials: The Advantages of Using a Global Specialist  
view
bullet
EVENT PREVIEWS
Rome, 'The Eternal City', will host the 15th Annual DIA EuroMeeting in March 2003. In a preview, The Drug Information Association outlines the agenda and programme news for the event to be held this coming spring  
InfoTechPharma is the unique world meeting place for information technology specialists and R&D professionals working in the pharmaceutical and biotechnology industries. In InfoTechPharma 2003, The 7th Annual Conference and Free Exhibition, event organisers IBC Life Sciences inform us of what's in store  
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Nanobiotix presents NBTXR3 preclinical data


More info >>

White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)


More info >>

Industry Events

14th Annual Biomarkers & Immuno-Oncology World Congress

11-13 June 2018, Westin Boston Waterfront, Boston, Massachusetts

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement